The Claim
Complete deletion of the Angptl7 gene in mice reduces basal intraocular pressure by approximately 2 mmHg (11%), and partial reduction of Angptl7 expression in heterozygous mice reduces basal intraocular pressure by 1.1 mmHg (6%), indicating a dose-dependent relationship between Angptl7 gene dosage and intraocular pressure regulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice, removing both copies of the Angptl7 gene lowers eye pressure by about 2 mmHg, and removing one copy lowers it by 1.1 mmHg, showing that the amount of Angptl7 gene activity directly affects eye pressure levels.
See the scientific wording
In mice, complete deletion of the Angptl7 gene reduces basal intraocular pressure by approximately 2 mmHg (11%), while partial reduction in heterozygous mice lowers pressure by 1.1 mmHg (6%), demonstrating a dose-dependent effect of ANGPTL7 on intraocular pressure regulation.
When the ANGPTL7 protein is reduced, the trabecular meshwork builds less stiff structural material, allowing fluid in the eye to drain more easily, which lowers the pressure inside the eye.
What the research says
1 studyStudy: ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma
Mice born without the Angptl7 gene have lower eye pressure, and mice with only one copy of the gene have a smaller drop in pressure — showing that the more of this gene you have, the higher your eye pressure. This proves the gene directly affects eye pressure.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.